NCT04146324Completed
An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia
A Prospective Observational Study in Patients Receiving Adjuvant Nivolumab Therapy for Resected Melanoma in Australia
Source: ClinicalTrials.gov · Last updated 24 Jan 2025
Brief summary (registry, in English)
This study is designed to estimate the effectiveness of nivolumab when given to participants after removing their cancer with surgery, over a 5-year follow-up, in real-world conditions in Australia.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 29 Oct 2019
- Start date
- 12 Dec 2019
- Primary completion date
- 31 May 2024
- Lead sponsor
- Bristol-Myers Squibb
- Diseases
- Melanoma
- NCT number
- NCT04146324
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 12 Dec 2019 to the primary completion date, 31 May 2024
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Adults with a current diagnosis of persisting advanced melanoma
- Adults currently enrolled in an interventional clinical trial for his/her melanoma treatment
- Other protocol-defined inclusion/exclusion criteria apply
Who the study is looking for
- Adults with a primary diagnosis of melanoma with involvement of lymph nodes or metastatic disease who have undergone complete surgical removal and have no evidence of disease
- Decision to treat with adjuvant nivolumab therapy has already been taken
- Ability to provide written informed consent to participate in the study
Criteria the registry did not label
- For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Birtinya | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Box Hill | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Cairns | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Garran | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Greenslopes | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Herston | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Malvern | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Woodville South | Australia | Unknown status |
| - Coordinator of this site? Confirm its status | Woolloongabba | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.